ライフサイエンスコーパス: vaccinate

1 s (48% vaccinated) and 1,640 controls (54.5% vaccinated).

2 ferent proportions of populations willing to vaccinate.

3 onal cases of bursitis per 1 million persons vaccinated.

4 100,000 persons among those who had not been vaccinated.

5 which individuals are morally obliged to get vaccinated.

6 accinated earlier than October failed to get vaccinated.

7 inated in August and September failed to get vaccinated.

8 76 945 girls and women, of whom 485 408 were vaccinated.

9 eaks occurring in young adults who have been vaccinated.

10 re, and 10.8% (n = 107) did not intend to be vaccinated.

11 gible; only 68 (5%) of 1361 were known to be vaccinated.

12 Vaccinating 1 mo later required using 50% more vaccine d

13 Vaccine-type HPV prevalence was lower among vaccinated (22.9%) compared with unvaccinated (31.6%) pa

14 tients (38%) with known CSF leakage had been vaccinated (23-valent pneumococcal vaccine in 9 patients

15 C57BL/6 female mice were vaccinated 3 weeks apart with DeltagD-2, and pups were c

16 We vaccinated 30 rhesus macaques with Ad26-SIV Env/Gag/Pol

17 .6% of participants (n = 571) intended to be vaccinated, 31.6% (n = 313) were not sure, and 10.8% (n

18 It is estimated that vaccinating 50%-70% of school-aged children for influenz

19 Sixty-six percent of the patients had been vaccinated according to the current guidelines.

20 lmonary TB (APTB) cases, and 24 recently BCG-vaccinated adolescents and naive controls.

21 ody seroresponses were observed in 71% of 24 vaccinated adults, and antibody levels were highly corre

22 nt OPV2 in previously OPV-vaccinated and IPV-vaccinated adults.

23 social concern led to stronger intentions to vaccinate against influenza and COVID-19 but only when s

24 These findings provide a rationale to vaccinate against mosquito saliva instead of the pathoge

25 on programs, most people worldwide have been vaccinated against common pathogens, leading to acquired

26 Intent to be vaccinated against COVID-19 was measured with the questi

27 vaccination and 1 in 10 did not intend to be vaccinated against COVID-19.

28 Women vaccinated against HPV have a lower incidence of cervica

29 Among HCWs fully vaccinated against measles, mumps, and VZV, Bio-Rad MFI/

30 -Rad MFI was positive in 83.7% of HCWs fully vaccinated against rubella.

31 International guidelines recommend vaccinating allogeneic hematopoietic cell transplant (HC

32 On the contrary, if the other doesn't vaccinate and violates the social contract, generosity s

33 an antibody response to HBV, we screened 124 vaccinated and 20 infected, spontaneously recovered indi

34 tive cohort initiated in 2009, including 744 vaccinated and 294 unvaccinated girls (1993-1994) who pr

35 per 100,000 persons among women who had been vaccinated and 94 cases per 100,000 persons among those

36 sease; 69 were old enough to have been fully vaccinated and considered protected.

37 was no difference in nasal shedding between vaccinated and control SARS-CoV-2-infected macaques.

38 nogenic as monovalent OPV2 in previously OPV-vaccinated and IPV-vaccinated adults.

39 dium, with no observable differences between vaccinated and naive animals.

40 pulations as distinguishing features between vaccinated and naive mice.

41 ge prevalence half-life is similar among PCV-vaccinated and PCV-unvaccinated children (3.26 and 3.34

42 ponsiveness, a cohort of pigs (n = 120) were vaccinated and pigs representing the high (n = 6; 90th p

43 with decreased survival compared to animals vaccinated and subsequently treated with MIL77.

44 the nasopharynx with CAAP case status, among vaccinated and unvaccinated children.

45 In 2010-2014, cervicovaginal samples from vaccinated and unvaccinated girls at age 18.5 years were

46 derive adjusted odds of case status between vaccinated and unvaccinated individuals; VE estimates we

47 We compared HPV prevalence among vaccinated and unvaccinated participants and determined

48 57 patients, there were 717 PPV23 cases (48% vaccinated) and 1,640 controls (54.5% vaccinated).

49 lar challenge with HSV-1 compared to vehicle-vaccinated animals based on survival and reduced corneal

50 Vaccinated animals developed humoral and cellular immune

51 While all sham-vaccinated animals developed viraemia, high tissue viral

52 a comparing vaccinated mice, HSV-1 0DeltaNLS-vaccinated animals possessed significantly less infectio

53 loads and CCHF-induced disease, the NP + GPC vaccinated animals were significantly protected.

54 of purified immunoglobulin G (IgG) from the vaccinated animals with the most robust protective signa

55 monitor seroconversion in both infected and vaccinated animals.

56 tlands) and perennial rivers and in recently vaccinated animals.

57 with upregulation of interferon pathways in vaccinated animals.

58 for all 4 glycoproteins were detected in all vaccinated animals.

59 nge of at least 30% in proportion willing to vaccinate as risk of infection increases.

60 ndividuals that might need to be shielded or vaccinated as the global pandemic unfolds.

61 l 2-dose RZV schedule by following-up adults vaccinated at >=60 YOA and by modeling, and (2) immunoge

62 083 women, of which 215 309 (36%) women were vaccinated at <=16 years, and among these, 40 742 (19%)

63 Among women vaccinated at <=18 years, adjusted PRs for 1, 2, and 3 d

64 determine whether the proportion of patients vaccinated at a dialysis facility differs according to t

65 substantial protection against GWs in girls vaccinated at age <=16 years.

66 Girls were vaccinated at age 9 years (with a catch-up to age 14 yea

67 The average proportion of patients vaccinated at each facility decreased significantly from

68 % CI, 0.27 to 0.75) among women who had been vaccinated at the age of 17 to 30 years.

69 t antibody isotype switching, since both PIV-vaccinated B2m KO and MHC-II KO mice produced less Coxie

70 for HBV infection, including those who were vaccinated before being screened for HBV infection.

71 % CI, 0.00 to 0.34) among women who had been vaccinated before the age of 17 years and 0.47 (95% CI,

72 We studied 12.7 million vaccinated beneficiaries.

73 in an independent cohort of 302 individuals vaccinated between 8 am and 12 pm with BCG.RESULTSCompar

74 ared with 36 age- and sex-matched volunteers vaccinated between 8 am and 9 am.

75 099 participants were randomly assigned and vaccinated between Sept 7, 2016, and Aug 18, 2017; 19 02

76 Although vaccinated birds had higher titers of hemagglutination-i

77 nfectious virus themselves, when infected by vaccinated birds.

78 However, only immune serum from DeltagD-2-vaccinated, but not rgD-2-vaccinated, mice provided sign

79 Female C3H/HeN mice were vaccinated by mucosal and systemic routes with C. tracho

80 The number of students vaccinated by the SLIV intervention ranged from 7,502 to

81 Depletion of IL-17A in vaccinated C57BL/6 mice prior to challenge abrogated the

82 roup invasive meningococcal disease in fully vaccinated cases compared with controls and group B and

83 up B invasive meningococcal disease in fully vaccinated cases compared with controls.

84 ood mononuclear cell conditioned medium from vaccinated cattle upon apical-basolateral migration of B

85 ely, transfer of naive CD4(+) T cells to PIV-vaccinated CD4 KO mice exacerbates disease.

86 try of Health launched a vaccine campaign to vaccinate children-who had only received the inactivated

87 This includes among PCV-vaccinated children 3-5-year-old (16.1% relative reducti

88 A comparison group comprised wP-vaccinated children born to mothers not vaccinated durin

89 High-density peptide analysis revealed that vaccinated children had increases in seroreactivity to f

90 es of invasive pneumococcal disease in fully vaccinated children have occurred in Australia since 201

91 the benefit-risk ratio to the households of vaccinated children is 3 (0-10); if the risk to only the

92 The benefit-risk ratio for the vaccinated children is 85 000 (4900-546 000), for their

93 hildren is 3 (0-10); if the risk to only the vaccinated children is considered, the benefit-risk rati

94 nd pneumococcal vaccination among previously vaccinated children treated for ALL.

95 High and persistent rotavirus shedding among vaccinated children with breakthrough disease may contri

96 CV13 has reduced serotype 19A carriage among vaccinated children.

97 accination clinic visits, especially for the vaccinated children.

98 s in some countries, will be more notable as vaccinated cohorts age.

99 d infection within 6-8 weeks, while all mock vaccinated controls became infected with high-level vire

100 We found that while isotype-treated vaccinated controls were protected against an otherwise

101 Compared to vaccinated controls, neutrophil-depleted mice had higher

102 %) and 39 of 175 controls (22.3%) were fully vaccinated (difference, -15.2% [95% CI, -24.3% to -6.1%]

103 %) and 33 of 142 controls (23.1%) were fully vaccinated (difference, -16.0% [95% CI, -26.3% to -5.7%]

104 Vaccinating dogs against rabies is an effective means of

105 4 years after B cells were isolated from the vaccinated donor.

106 dence interval [CI], 4.3%-27.4%) of patients vaccinated during maintenance (group 1) achieved a prote

107 d wP-vaccinated children born to mothers not vaccinated during pregnancy.

108 nts and 78% of controls had mothers who were vaccinated during pregnancy.

109 facilities, the mean percentage of patients vaccinated during the influenza season was 72.1%.

110 en 0% and 50% of individuals who usually get vaccinated earlier than October failed to get vaccinated

111 increase, greater efforts should be made to vaccinate eligible adults 50 years of age and older.

112 xhibited similar acute viral loads; however, vaccinated females, but not males, exhibited lower level

113 come was the proportion of facility patients vaccinated for influenza among 6735 Medicare-certified f

114 ive for influenza, and 50.6% were considered vaccinated for that season.

115 innate immune populations that distinguished vaccinated from naive mice within 10 days, and persisted

116 Notably, elderly-centric programmes vaccinating from 65-75 years and above had the least per

117 Nevertheless, the vaccinated gBT-I.1 mice were resistant to ocular challen

118 as more common among unvaccinated girls than vaccinated girls (9.2% vs. 3.7%).

119 pected among both unvaccinated (p=0.002) and vaccinated girls (p<0.001).

120 he study population consisted of 314,017 HPV-vaccinated girls and 314,017 age-matched HPV-unvaccinate

121 and a 72% increase in DALYs averted per 1000 vaccinated girls for both the bivalent or quadrivalent a

122 from the pre-vaccination cohort (n=5245) and vaccinated girls from the vaccine-eligible cohort (n=490

123 adjusted life-years (DALYs) averted per 1000 vaccinated girls in comparison with the counterfactual s

124 15 cases, 12 deaths, and 243 DALYs per 1000 vaccinated girls, and the nonavalent HPV vaccine was est

125 Vaccine efficacy for vaccinated girls, HE for unvaccinated girls, and the pro

126 in co-infection among both unvaccinated and vaccinated girls.

127 19 cases, 14 deaths, and 306 DALYs per 1000 vaccinated girls.

128 e significantly lower than those of the sham-vaccinated group (P <= 0.05).

129 (TG) and brain stem compared to the control-vaccinated group.

130 ific CD8(+) T cells from the HSV-1 0DeltaNLS-vaccinated group.

131 Most vaccinated groups had prolonged mean death times (MDT),

132 challenge in seven of eight animals in both vaccinated groups.

133 Guinea pigs were bred and vaccinated guinea pigs were challenged at mid-gestation

134 protection from lung disease in most of the vaccinated hamsters within as little as 10 days.

135 antibodies in presumptively immune or fully vaccinated HCWs.

136 y to induce elevated interferon responses in vaccinated hosts.

137 induce elevated interferon responses in the vaccinated hosts.

138 ons if more than 14% of older adults usually vaccinated in August and September failed to get vaccina

139 ndividuals born between 1997 and 2005, fully vaccinated in England, were included.

140 se B cells can be adoptively transferred and vaccinated in immunocompetent mice resulting in the expa

141 ith 95% confidence if 86% of FGD flocks were vaccinated in the best-case scenario or 95% in the worst

142 egnancies were identified: 6,872 (8.8%) were vaccinated in the first trimester, 11,678 (14.9%) in the

143 Most vaccines protect both the vaccinated individual and the society by reducing the tr

144 xamine the extent of convergent evolution in vaccinated individuals and the amount of viral diversity

145 ine substantially reduces viral load in both vaccinated individuals and unvaccinated contact individu

146 cell responses in Lassa fever survivors and vaccinated individuals as well as for designing vaccines

147 Vaccinated individuals can become colonized and transmit

148 dence that LTBI prevalence was lower amongst vaccinated individuals even >20 years after vaccination,

149 Waning measles immunity among vaccinated individuals may result in an attenuated illne

150 If so, vaccinated individuals should reciprocate by being more

151 this pattern was especially pronounced among vaccinated individuals who perceived vaccination as a mo

152 Quantifying rotavirus shedding among vaccinated individuals will aid understanding of vaccine

153 g antibodies, which are commonly elicited in vaccinated individuals, may be markedly enhanced by alte

154 unity within a single influenza season among vaccinated individuals.

155 ntly showed that especially compliant (i.e., vaccinated) individuals showed less generosity toward no

156 BCG-vaccinated infants also had increased production of MIG

157 antibody functionality was higher in all wP-vaccinated infants at all times.

158 immunoglobulin G, were observed among 69 wP-vaccinated infants born to control mothers compared with

159 ited more pertussis-specific responses in wP-vaccinated infants compared to aP-vaccinated infants, an

160 Compared to BCG-naive infants, BCG-vaccinated infants had increased production of interfero

161 higher in acellular pertussis (aP)- than wP-vaccinated infants of immunized mothers, yet quality of

162 nts born to control mothers compared with wP-vaccinated infants of Tdap-vaccinated mothers after prim

163 nses in wP-vaccinated infants compared to aP-vaccinated infants, and the control group of unvaccinate

164 Pam3CYSK4) stimulation were increased in BCG-vaccinated infants.

165 0.0011), and that the proportion willing to vaccinate is related to both ideology and the level of r

166 passive transfer of purified antibodies from vaccinated macaques can protect naive animals against SI

167 ycoproteins was also detected in most of the vaccinated macaques.

168 hemagglutinin and neuraminidase was used to vaccinate mice, it provided enhanced protection against

169 In BCG-vaccinated mice and guinea pigs, metformin enhances immu

170 in the near absence of anti-HSV-1 antibody, vaccinated mice are protected from subsequent challenge

171 uction in virus replication were observed in vaccinated mice challenged with HSV-1, cornea pathology

172 gBT-I.1-vaccinated mice did not generate a robust neutralization

173 Following challenge, vaccinated mice exhibited reduced bacterial burden and s

174 e of BCG-specific Th cells in previously BCG-vaccinated mice had a dose-sparing effect for subsequent

175 We found that the sera from CspZ-YA-vaccinated mice more efficiently eliminated spirochetes

176 pletion of CD8(+) T cells in HSV-1 0DeltaNLS-vaccinated mice rendered animals highly susceptible to v

177 mber of embryos, and hydrosalpinx formation, vaccinated mice were protected against challenges with s

178 g a mouse-adapted SARS-CoV-2, virus loads in vaccinated mice were significantly lower, while vaccinat

179 Finally, in splenocytes of DNA.HTI-vaccinated mice, costimulation of HTI peptides and a DR3

180 us titer recovered from the cornea comparing vaccinated mice, HSV-1 0DeltaNLS-vaccinated animals poss

181 -approved lipid nanoparticle material MC3 in vaccinated mice.

182 virus-mediated mortality similar to control-vaccinated mice.

183 ing on these observations, we tested whether vaccinating mice with an epicutaneous influenza patch co

184 rum from DeltagD-2-vaccinated, but not rgD-2-vaccinated, mice provided significant protection against

185 as seropositive by dengue IgG ELISA and then vaccinated might be at risk of developing severe disease

186 compared with wP-vaccinated infants of Tdap-vaccinated mothers after primary and booster vaccination

187 ears before enrollment (n = 53) or never GBS vaccinated (n = 27) received a single trivalent GBS vacc

188 rammed cell death in the parasites, and that vaccinating non-human primates with PfGARP partially pro

189 disease-burden data, political challenges of vaccinating only a portion of a population, and potentia

190 Vaccinating only farmers required 10 times as more vacci

191 l a worst-case scenario using rhesus monkeys vaccinated or unvaccinated with the rVSV-ZEBOV vaccine.

192 ould reciprocate by being more generous to a vaccinated other.

193 To that end, 12 RMs were vaccinated over 81 weeks with DNA, modified vaccinia Ank

194 IPV-vaccinated participants were randomly assigned to receiv

195 In previously OPV-vaccinated participants, 286 (97%) of 296 were seroposit

196 After first doses in previously OPV-vaccinated participants, 62 (62%) of 100 monovalent OPV2

197 In IPV-vaccinated participants, solicited adverse events occurr

198 concatenated into a single mRNA construct to vaccinate patients with metastatic gastrointestinal canc

199 specific immune responses, and fewer Triplex-vaccinated patients had CMV viremia.

200 Because only half of the vaccinated patients had long-term protection, pending pr

201 The share of vaccinated patients in facilities in the quartile with t

202 A subset analysis of vaccinated patients newly treated with anti-programmed c

203 antly from 2014 to 2017 (a decrease of 1.05% vaccinated per year) and decreased significantly more so

204 The cohort included 2 943 493 vaccinated persons.

205 dherence to international recommendations to vaccinate PLWH.

206 cidence rate ratio for the comparison of the vaccinated population with the unvaccinated population w

207 Safety was assessed in the total vaccinated population-ie, all participants who received

208 ne or placebo and were included in the total vaccinated population.

209 tes of age-specific risk and VE in similarly vaccinated populations and thus improve forecasting and

210 in offspring, supporting recommendations to vaccinate pregnant women.

211 nd mRNA-LNP groups, though not in ectodomain-vaccinated rabbits.

212 uencing of a putative RHV escape mutant in a vaccinated rat identified mutations in both identified i

213 tion-to-behavior gap for those willing to be vaccinated rather than focusing on those hesitant about

214 0 times the minimum infectious dose), 42% of vaccinated rats cleared infection within 6-8 weeks, whil

215 ble a phage display library from human CD160-vaccinated rats.

216 Residents' influenza vaccination status (vaccinated, refused, and not offered) was assessed.

217 human rabies, but only deploys Catch-Neuter-Vaccinate-Release (CNVR) for FRD control as a humane alt

218 coronavirus becomes available, will you get vaccinated?" Response options were "yes," "no," and "not

219 fluid and lower respiratory tract tissue of vaccinated rhesus macaques that were challenged with SAR

220 However, kinetics of viral load control by vaccinated RM were considerably delayed compared to prev

221 ol animals, and no pneumonia was observed in vaccinated SARS-CoV-2-infected animals.

222 ne-enhanced disease after viral challenge in vaccinated SARS-CoV-2-infected animals.

223 timal strategy in all models, but in 1 model vaccinating seronegative women at 19-21 years of age was

224 eins NS3-NS5B from RHV (ChAd-NS) was used to vaccinate Sprague-Dawley rats, resulting in high levels

225 isparity in their responses, with previously vaccinated subjects exhibiting significantly blunted CD4

226 or altered antibody responses in repeatedly vaccinated subjects.

227 cinated mice were significantly lower, while vaccinated Syrian hamsters revealed protection in a hars

228 gnificant differences in disease between PIV-vaccinated Tbet KO and CD4 KO mice.

229 ality invokes a larger proportion willing to vaccinate than mere morbidity (P = 0.0002), that older p

230 oved by integrating these approaches, namely vaccinating the neonate under the cover of vertically tr

231 ith the same vaccination coverage (70% fully vaccinated), the median probability of elimination after

232 upation with infecting others if they do not vaccinate themselves, motivates vaccination in more and

233 e design of possible strategies to shield or vaccinate those at highest risk.

234 nation, and the number of girls needed to be vaccinated to prevent a single case, death, or DALY.

235 Cynomolgus macaques were vaccinated twice with the quadrivalent formulation, foll

236 etermined factors associated with failure to vaccinate using spatial and multivariate logistic regres

237 tive risk of detecting these serotypes among vaccinated versus unvaccinated controls.

238 HPV-16 prevalence was significantly lower in vaccinated versus unvaccinated females (0.5% vs 5.6%, P

239 ed VE, comparing the odds of influenza among vaccinated versus unvaccinated participants.

240 , 2018, and Feb 27, 2019, 200 previously OPV-vaccinated volunteers were assigned to the four groups t

241 In an analysis of vaccinated volunteers, NHPs, and mice, we found that rec

242 ited responses to the PfCSP repeat region in vaccinated volunteers, potentially protective subdominan

243 Participants' intent to be vaccinated was explored before a vaccine was available a

244 13) serotype pneumonia (n = 417 cases, 43.7% vaccinated) was 29% (95% CI 6%-46%).

245 idity information, the proportion willing to vaccinate went from 0.476 (0.449-0.503) at 0 local cases

246 6 in 10 respondents said that they will get vaccinated when a vaccine for coronavirus disease 2019 b

247 y titer in comparison to the HSV-1 0DeltaNLS-vaccinated wild-type C57BL/6 counterpart.

248 in Coccidioides-infected lungs compared with vaccinated wild-type mice, especially Th17 cells.

249 ty, which relates a change in willingness to vaccinate with a change in perceived risk of infection-h

250 Healthy women either previously vaccinated with 1 dose of trivalent GBS vaccine 4-6 year

251 e cervical precancerous lesions, among women vaccinated with 1, 2, or 3 doses at <=16 years of age.

252 Fifty percent of rhesus macaques (RM) vaccinated with a combined RhCMV-Gag, -Env, and -Retanef

253 Cynomolgus macaques were vaccinated with a DNA-based vaccine using in vivo electr

254 ition, serum samples from healthy volunteers vaccinated with a measles-vectored chikungunya vaccine c

255 cted against lethal pneumonia, whereas those vaccinated with all 3 toxoids had 100% protection agains

256 After maternal Tdap vaccination, 158 infants vaccinated with aP-containing vaccines possessed higher

257 After maternal Tdap vaccination, 158 infants vaccinated with aP-containing vaccines possessed higher

258 ned immunity.METHODSEighteen volunteers were vaccinated with BCG at 6 pm and compared with 36 age- an

259 e were 140 and 130 admissions among neonates vaccinated with BCG-Denmark and BCG-Russia, respectively

260 DBA/2J mice vaccinated with COBRA vaccines showed increase survival

261 eins of RV A viruses, mice were sequentially vaccinated with DNA plasmids encoding capsid proteins of

262 a were enrolled into part A of the study and vaccinated with either: HD-MAPs delivering 15 mug of A/S

263 We compared antibody responses in humans vaccinated with Fluzone (egg-based, n = 23), Fluzone Hig

264 We compared antibody responses in humans vaccinated with Fluzone (egg-based, n=23), Fluzone High-

265 Participants (20 per group) were vaccinated with HD-MAPs delivering doses of 15, 10, 5, 2

266 Rabbits vaccinated with Hla toxoid alone or PVL components alone

267 ice using a transgenic mouse (gBT-I.1) model vaccinated with HSV-1 0DeltaNLS.

268 roup); a further 50 participants, previously vaccinated with IPV, were assigned to novel OPV2-c1 (n=1

269 ved remission after immunochemotherapy, were vaccinated with irradiated, CpG-activated tumor cells.

270 Children vaccinated with LAIV had serum and mucosal antibody resp

271 fic, MHC-E-restricted CD8(+) T cells from RM vaccinated with RM CMV vaccine vectors expressing HBV Ag

272 onses in healthy malaria-naive adults (N=45) vaccinated with RTS,S/AS01.

273 ZVL-naive individuals (HZ-NonVac, N=215) and vaccinated with RZV.

274 ring pregnancy, nonpregnant guinea pigs were vaccinated with S19, 16MDeltavjbR + Quil-A, or 100 mul P

275 08926) followed term infants born to mothers vaccinated with tetanus, diphtheria, and acellular pertu

276 included healthy children 3 to 6 years old (vaccinated with the 13-valent pneumococcal conjugate vac

277 e adults aged 18-50 yr (average, 29 yr) were vaccinated with the Ebola vaccine candidate chimpanzee a

278 dy binding data obtained from human subjects vaccinated with the monovalent 2009 H1N1 influenza vacci

279 Two were isolated from a young adult vaccinated with trivalent influenza vaccine (TIV), which

280 efined as 1 minus the hazard ratio comparing vaccinated with unvaccinated children.

281 Mice were vaccinated with virus-like particles (VLPs) expressing o

282 Mice were vaccinated with VLPs expressing HA antigens that lacked

283 Adults aged >=65 years previously vaccinated with ZVL >=5 years before (HZ-PreVac, N=215)

284 (95% CI, 15-73%), nonsignificantly higher if vaccinated within 2 years (63%; -5-87%).

285 ceeded postdose 1 GMCs in previously non-GBS-vaccinated women (>=7-fold).

286 was 3.41 per 1,000 person-years in the Tdap-vaccinated women and 3.93 per 1,000 person-years in the

287 s were compared between unvaccinated and HPV-vaccinated women born 1994-2005.

288 BS levels, postdose 2 GMCs in previously GBS-vaccinated women exceeded postdose 1 GMCs in previously

289 MCs) 30/60 days postdose 2 in previously GBS-vaccinated women were >=200-fold higher than baseline GM

290 characteristics and antibody levels between vaccinated women with and those without HPV infections 1

291 Of previously GBS-vaccinated women with undetectable baseline (predose 1)

292 Of previously GBS-vaccinated women, 92%-98% had anti-GBS concentrations th

293 vs 36%-56% postdose 1 in previously non-GBS-vaccinated women.

294 er was 90%-120% across assays for infants of vaccinated women.

295 Vaccinating women and men up to age 30, 40, and 45 years

296 l immunity in a pathogen-agnostic fashion or vaccinating women during pregnancy to induce protective

297 Adoptive transfer of CD4(+) T cells from PIV-vaccinated WT mice to naive CD4-deficient (CD4 KO) mice

298 produced less Coxiella-specific IgG than PIV-vaccinated WT mice.

299 The re-emergence of mumps among vaccinated young adults has become a global issue.

300 ntral role in the reemergence of mumps among vaccinated young adults.